adenine has been researched along with Nasal Bleeding in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Ibrutinib combined with rituximab is active and well tolerated in patients with relapsed or refractory mantle cell lymphoma." | 2.82 | Ibrutinib in combination with rituximab in relapsed or refractory mantle cell lymphoma: a single-centre, open-label, phase 2 trial. ( Addison, A; Badillo, M; Champlin, R; Chen, W; Chuang, H; DeLa Rosa, M; Fayad, L; Hagemeister, F; Lam, L; Lee, H; Li, S; Medeiros, LJ; Nomie, K; Oki, Y; Romaguera, J; Samaniego, F; Santos, D; Turturro, F; Wagner-Bartak, N; Wang, ML; Westin, J; Young, KH; Zhang, H; Zhang, L; Zhao, D, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, ML | 1 |
| Lee, H | 1 |
| Chuang, H | 1 |
| Wagner-Bartak, N | 1 |
| Hagemeister, F | 1 |
| Westin, J | 1 |
| Fayad, L | 1 |
| Samaniego, F | 1 |
| Turturro, F | 1 |
| Oki, Y | 1 |
| Chen, W | 1 |
| Badillo, M | 1 |
| Nomie, K | 1 |
| DeLa Rosa, M | 1 |
| Zhao, D | 1 |
| Lam, L | 1 |
| Addison, A | 1 |
| Zhang, H | 1 |
| Young, KH | 1 |
| Li, S | 1 |
| Santos, D | 1 |
| Medeiros, LJ | 1 |
| Champlin, R | 1 |
| Romaguera, J | 1 |
| Zhang, L | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Phase II Study of Ibrutinib Plus Rituximab in Patients With Relapsed/Refractory Mantle Cell Lymphoma or Elderly Patients With Newly Diagnosed MCL[NCT01880567] | Phase 2 | 113 participants (Actual) | Interventional | 2013-07-15 | Active, not recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for adenine and Nasal Bleeding
| Article | Year |
|---|---|
Ibrutinib in combination with rituximab in relapsed or refractory mantle cell lymphoma: a single-centre, open-label, phase 2 trial.
Topics: Adenine; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Atrial Fibrillatio | 2016 |